212 related articles for article (PubMed ID: 32599298)
61. Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity.
Kracht MJL; Zaldumbide A; Roep BO
Trends Endocrinol Metab; 2016 Jun; 27(6):353-362. PubMed ID: 27094501
[TBL] [Abstract][Full Text] [Related]
62. Science Signaling Podcast for 21 June 2016: Nanoparticles to treat type 1 diabetes.
Quintana FJ; VanHook AM
Sci Signal; 2016 Jun; 9(433):c15. PubMed ID: 27330187
[TBL] [Abstract][Full Text] [Related]
63. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
[TBL] [Abstract][Full Text] [Related]
64. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
65. Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.
Negi S; Rutman AK; Paraskevas S
Curr Diab Rep; 2019 Jul; 19(9):69. PubMed ID: 31367976
[TBL] [Abstract][Full Text] [Related]
66. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
67. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
[TBL] [Abstract][Full Text] [Related]
68. Role of humoral beta-cell autoimmunity in type 1 diabetes.
Knip M; Siljander H; Ilonen J; Simell O; Veijola R
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():17-24. PubMed ID: 27411432
[TBL] [Abstract][Full Text] [Related]
69. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
70. Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes.
Kodama K; Zhao Z; Toda K; Yip L; Fuhlbrigge R; Miao D; Fathman CG; Yamada S; Butte AJ; Yu L
Diabetes; 2016 May; 65(5):1341-9. PubMed ID: 26983959
[TBL] [Abstract][Full Text] [Related]
71. HIPs and HIP-reactive T cells.
Wiles TA; Delong T
Clin Exp Immunol; 2019 Dec; 198(3):306-313. PubMed ID: 31132145
[TBL] [Abstract][Full Text] [Related]
72. Post-translational protein modifications in antigen recognition and autoimmunity.
Doyle HA; Mamula MJ
Trends Immunol; 2001 Aug; 22(8):443-9. PubMed ID: 11473834
[TBL] [Abstract][Full Text] [Related]
73. Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis.
McLaughlin RJ; Spindler MP; van Lummel M; Roep BO
Curr Diab Rep; 2016 Jul; 16(7):63. PubMed ID: 27168063
[TBL] [Abstract][Full Text] [Related]
74. Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential.
Rodriguez-Fernandez S; Murillo M; Villalba A; Perna-Barrull D; Cano-Sarabia M; Gomez-Muñoz L; Aguilera E; Maspoch D; Vazquez F; Bel J; Vives-Pi M
Front Immunol; 2019; 10():2811. PubMed ID: 31849983
[TBL] [Abstract][Full Text] [Related]
75. Experiments by nature: lessons on type 1 diabetes.
Battaglia M
Tissue Antigens; 2014 Jan; 83(1):1-9. PubMed ID: 24355002
[TBL] [Abstract][Full Text] [Related]
76. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review.
Gomez-Tourino I; Arif S; Eichmann M; Peakman M
J Autoimmun; 2016 Jan; 66():7-16. PubMed ID: 26343335
[TBL] [Abstract][Full Text] [Related]
77. High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model.
Davidson HW; Cepeda JR; Sekhar NS; Han J; Gao L; Sosinowski T; Zhang L
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475985
[TBL] [Abstract][Full Text] [Related]
78. Gene therapy in type 1 diabetes.
Bagley J; Paez-Cortez J; Tian C; Iacomini J
Crit Rev Immunol; 2008; 28(4):301-24. PubMed ID: 19166382
[TBL] [Abstract][Full Text] [Related]
79. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
[TBL] [Abstract][Full Text] [Related]
80. Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update.
Wan X; Unanue ER
Curr Opin Immunol; 2017 Jun; 46():30-37. PubMed ID: 28456018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
